842 related articles for article (PubMed ID: 18651694)
21. Indole naphthyridinones as inhibitors of bacterial enoyl-ACP reductases FabI and FabK.
Seefeld MA; Miller WH; Newlander KA; Burgess WJ; DeWolf WE; Elkins PA; Head MS; Jakas DR; Janson CA; Keller PM; Manley PJ; Moore TD; Payne DJ; Pearson S; Polizzi BJ; Qiu X; Rittenhouse SF; Uzinskas IN; Wallis NG; Huffman WF
J Med Chem; 2003 Apr; 46(9):1627-35. PubMed ID: 12699381
[TBL] [Abstract][Full Text] [Related]
22. Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
Perdih A; Hrast M; Barreteau H; Gobec S; Wolber G; Solmajer T
Bioorg Med Chem; 2014 Aug; 22(15):4124-34. PubMed ID: 24953950
[TBL] [Abstract][Full Text] [Related]
23. New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation.
Zidar N; Tomašić T; Šink R; Kovač A; Patin D; Blanot D; Contreras-Martel C; Dessen A; Premru MM; Zega A; Gobec S; Mašič LP; Kikelj D
Eur J Med Chem; 2011 Nov; 46(11):5512-23. PubMed ID: 21963114
[TBL] [Abstract][Full Text] [Related]
24. 2-Aminotetralones: novel inhibitors of MurA and MurZ.
Dunsmore CJ; Miller K; Blake KL; Patching SG; Henderson PJ; Garnett JA; Stubbings WJ; Phillips SE; Palestrant DJ; Angeles Jde L; Leeds JA; Chopra I; Fishwick CW
Bioorg Med Chem Lett; 2008 Mar; 18(5):1730-4. PubMed ID: 18261901
[TBL] [Abstract][Full Text] [Related]
25. Triaminotriazine DNA helicase inhibitors with antibacterial activity.
McKay GA; Reddy R; Arhin F; Belley A; Lehoux D; Moeck G; Sarmiento I; Parr TR; Gros P; Pelletier J; Far AR
Bioorg Med Chem Lett; 2006 Mar; 16(5):1286-90. PubMed ID: 16343901
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2/4-benzaldehyde-amino) phenyl-N'-phenyl-thiourea.
Zhang HJ; Qin X; Liu K; Zhu DD; Wang XM; Zhu HL
Bioorg Med Chem; 2011 Sep; 19(18):5708-15. PubMed ID: 21872479
[TBL] [Abstract][Full Text] [Related]
27. MurD enzymes: some recent developments.
Šink R; Barreteau H; Patin D; Mengin-Lecreulx D; Gobec S; Blanot D
Biomol Concepts; 2013 Dec; 4(6):539-56. PubMed ID: 25436755
[TBL] [Abstract][Full Text] [Related]
28. Structure-based design of new DHFR-based antibacterial agents: 7-aryl-2,4-diaminoquinazolines.
Li X; Hilgers M; Cunningham M; Chen Z; Trzoss M; Zhang J; Kohnen L; Lam T; Creighton C; G C K; Nelson K; Kwan B; Stidham M; Brown-Driver V; Shaw KJ; Finn J
Bioorg Med Chem Lett; 2011 Sep; 21(18):5171-6. PubMed ID: 21831637
[TBL] [Abstract][Full Text] [Related]
29. Discovery of pyrazolthiazoles as novel and potent inhibitors of bacterial gyrase.
Ronkin SM; Badia M; Bellon S; Grillot AL; Gross CH; Grossman TH; Mani N; Parsons JD; Stamos D; Trudeau M; Wei Y; Charifson PS
Bioorg Med Chem Lett; 2010 May; 20(9):2828-31. PubMed ID: 20356737
[TBL] [Abstract][Full Text] [Related]
30. Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis.
Bratkovic T; Lunder M; Urleb U; Strukelj B
J Basic Microbiol; 2008 Jun; 48(3):202-6. PubMed ID: 18506905
[TBL] [Abstract][Full Text] [Related]
31. Discovery and optimization of antibacterial AccC inhibitors.
Cheng CC; Shipps GW; Yang Z; Sun B; Kawahata N; Soucy KA; Soriano A; Orth P; Xiao L; Mann P; Black T
Bioorg Med Chem Lett; 2009 Dec; 19(23):6507-14. PubMed ID: 19875284
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
[TBL] [Abstract][Full Text] [Related]
34. Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase.
Lira R; Xiang AX; Doundoulakis T; Biller WT; Agrios KA; Simonsen KB; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Banh VN; Steffy KR; Appleman JR
Bioorg Med Chem Lett; 2007 Dec; 17(24):6797-800. PubMed ID: 17980587
[TBL] [Abstract][Full Text] [Related]
35. Parallel solid synthesis of inhibitors of the essential cell division FtsZ enzyme as a new potential class of antibacterials.
Paradis-Bleau C; Beaumont M; Sanschagrin F; Voyer N; Levesque RC
Bioorg Med Chem; 2007 Feb; 15(3):1330-40. PubMed ID: 17157508
[TBL] [Abstract][Full Text] [Related]
36. Identification of an inhibitor of the MurC enzyme, which catalyzes an essential step in the peptidoglycan precursor synthesis pathway.
Zawadzke LE; Norcia M; Desbonnet CR; Wang H; Freeman-Cook K; Dougherty TJ
Assay Drug Dev Technol; 2008 Feb; 6(1):95-103. PubMed ID: 18315498
[TBL] [Abstract][Full Text] [Related]
37. High-throughput catch-and-release synthesis of oxazoline hydroxamates. Structure-activity relationships in novel inhibitors of Escherichia coli LpxC: in vitro enzyme inhibition and antibacterial properties.
Pirrung MC; Tumey LN; McClerren AL; Raetz CR
J Am Chem Soc; 2003 Feb; 125(6):1575-86. PubMed ID: 12568618
[TBL] [Abstract][Full Text] [Related]
38. Virtual screening for potential inhibitors of bacterial MurC and MurD ligases.
Tomašić T; Kovač A; Klebe G; Blanot D; Gobec S; Kikelj D; Mašič LP
J Mol Model; 2012 Mar; 18(3):1063-72. PubMed ID: 21667288
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationships of novel antibacterial translation inhibitors: 3,5-diamino-piperidinyl triazines.
Zhou Y; Sun Z; Froelich JM; Hermann T; Wall D
Bioorg Med Chem Lett; 2006 Oct; 16(20):5451-6. PubMed ID: 16890435
[TBL] [Abstract][Full Text] [Related]
40. Novel pyridazine derivatives: Synthesis and antimicrobial activity evaluation.
Kandile NG; Mohamed MI; Zaky H; Mohamed HM
Eur J Med Chem; 2009 May; 44(5):1989-96. PubMed ID: 19013692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
